Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964413
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2023-06-29
Brief Title:
Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
Sponsor:
InflaRx GmbH
Organization:
InflaRx GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pyoderma Gangrenosum |
Keywords: